|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,024.50 INR | -1.91% |
|
-0.44% | -5.76% |
| 14/11 | Divi's Labs Unit-I inspection by US FDA concluded | RE |
| 10/11 | Jefferies Adjusts Divi's Laboratories' Price Target to INR7,850 From INR7,150, Keeps at Buy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DIVI'S LABORATORIES LIMITED | Other Pharmaceuticals | -1.91% | -0.44% | -5.76% | -1.56% | +57.61% | 1.77TCr |  |  | |
Technical Rankings Surperformance
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition